Results 101 to 110 of about 204,330 (266)

Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres

open access: yesMycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background There is a lack of contemporary studies addressing the prevalence rates and antifungal susceptibility of bloodstream infections (BSI) caused by rare yeasts (RY) from the Saccharomycotina subphylum. Objectives This 16‐year multicentre study (2007–2023) aimed to assess the prevalence and antifungal susceptibility of rare yeasts ...
Carolina Palamin Buonafine   +12 more
wiley   +1 more source

Candida auris in the Healthcare Environment: Prevalence, Anti-Fungal Resistance, and Survival on Porous & Non-Porous Surfaces

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Candida auris is an emerging multidrug-resistant pathogenic yeast capable of causing severe illness in the healthcare environment. It spreads easily amongst patient populations, is often resistant to anti-fungal treatments and can survive on surfaces for
Brandon Smith, Richard Miller
doaj   +1 more source

Environmental Contamination with Candida Species in Multiple Hospitals Including a Tertiary Care Hospital with a Candida auris Outbreak

open access: yesPathogens and Immunity, 2019
Background: Environmental sources have been implicated as a potential source for exogenous acquisition of Candida species, particularly the emerging multidrug-resistant Candida auris.
Jessica Ann Kumar   +10 more
doaj   +1 more source

Synergistic Antifungal Effects of Honokiol and Fluconazole Against Oral Candida: Implications for Managing Drug‐Resistant Infections

open access: yesClinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Objectives Antifungal drug resistance poses a major challenge in treating oral Candida infections. This study aimed to evaluate the antifungal activity of Honokiol, alone and combined with Fluconazole, against oral Candida isolates, and to investigate its mechanism of action via ergosterol biosynthesis inhibition and cell wall disruption ...
Maribasappa Karched   +2 more
wiley   +1 more source

The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen

open access: yesPLoS Pathogens
Candida auris is an emerging fungal pathogen with unusual evolutionary history—there are multiple distinct phylogeographic clades showing a near simultaneous transition from a currently unknown reservoir to nosocomial pathogen.
Darian J. Santana   +2 more
semanticscholar   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

open access: yesMedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin   +12 more
wiley   +1 more source

Compounding Effects of Climate Warming and Antibiotic Resistance. [PDF]

open access: yes, 2020
Bacteria have evolved diverse mechanisms to survive environments with antibiotics. Temperature is both a key factor that affects the survival of bacteria in the presence of antibiotics and an environmental trait that is drastically increasing due to ...
Cruz-Loya, Mauricio   +4 more
core   +1 more source

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

open access: yesPLoS Pathogens, 2017
Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide. Candida bloodstream infections (BSI) cause significant mortality and elicit a major threat to intensive care unit (ICU ...
A. Chowdhary, C. Sharma, J. Meis
semanticscholar   +1 more source

Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses

open access: yesmBio, 2020
In less than a decade, C. auris has emerged in health care settings worldwide; this species is capable of colonizing skin and causing outbreaks of invasive candidiasis. In contrast to other Candida species, C. auris is unique in its ability to spread via
N. Chow   +24 more
semanticscholar   +1 more source

Profiling the host defense responses against Candida auris in a reliable Drosophila melanogaster infection model

open access: yesmLife, Volume 5, Issue 1, Page 51-67, February 2026.
Abstract The “superbug” Candida auris has been ranked as a priority fungal pathogen and is becoming a serious threat to public health. However, the underlying mechanisms of real‐world pathogen–host interactions remain elusive, in part due to the lack of powerful immunocompetent animal models.
Jie Li   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy